latest news releases from the newsroom
iLumen Files Patent Related to Private Company Benchmarking Service
ATLANTA, Dec. 1, 2004 (PRIMEZONE) -- iLumen Inc., a financial information and technology company headquartered in Atlanta, today filed a patent application on behalf of its wholly-owned subsidiary, iLumen Global Benchmarking, Inc. The patent covers the secure, web-based collection and analysis of private company business performance information, and the delivery of trending reports comparing the results of one company to a customized and aggregated peer group.
Brodsky & Smith, LLC
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against IMPAX Laboratories, Inc. -- IPXL
BALA CYNWYD, Penn., Dec. 1, 2004 (PRIMEZONE) -- Law offices of Brodsky & Smith, LLC today announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock and other securities of IMPAX Laboratories, Inc. ("IMPAX" or the "Company") (Nasdaq:IPXL), between May 5, 2004 and November 3, 2004 inclusive (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Northern District of California.
Big Cap Communications
Search Engines Exhaust $1,000,000 Give Away of Money Making Products by Driving People That Want to Earn $5,000, $10,000, $15,000 a Month or More to BruceBerman.Net Website
NEWPORT BEACH, Calif., Dec. 1, 2004 (PRIMEZONE) -- Publisher Berman Investment Group announced today that their recent Free Book and CD offer, which was made on the Internet, radio and television has exceeded the $1,000,000 mark and is driving consumers to their website to seize their limited time free offer. The offer includes Bruce A. Berman's breakthrough book "I GOT HERE. YOU CAN TOO!" and his "Making Money" CD, which together are a $100 value, for free. For more information or for your free copy, the company distributes their free book and CD offer at www.BruceBerman.net
Advanced Plant Pharmaceuticals, Inc.
Advanced Plant Pharmaceuticals Acquires 99 Percent of Mazal Plant Pharmaceuticals Inc., a Company Focused on Developing Three Drugs for FDA Approval Process.
NEW YORK, Dec. 1, 2004 (PRIMEZONE) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (OTCBB:APPI) confirmed today the closing of an asset sale agreement entered with Mazal Plant Pharmaceuticals Inc., a private Delaware corporation ("Mazal") whereby in exchange for of 7,000,000 shares of common stock of Mazal, APPI transferred intellectual property to Mazal relating to three whole plant pharmaceutical drugs. Mazal presently has 7,050,100 shares of common stock issued and outstanding. Mazal is focused on the FDA development, testing, manufacturing and selling of plant pharmaceutical drugs.